Use Self-Scheduling to book a primary care appointment online
Schedule now!
As of May 1, 2025, UK HealthCare will no longer be part of Cigna’s medical insurance network.
Cigna Q&A

Terrence A. Barrett, MD

  • Chief, Division of Digestive Diseases and Nutrition
REQUEST AN APPOINTMENT
Are you a physician?
Refer a Patient

Specialties

Conditions

Related Services

About

I am a board-certified gastroenterologist who specializes in General GI & inflammatory bowel disease (IBD). I am a tenured professor. I trained at University of Chicago (GI with a post-doc in Immunology) and moved to Northwestern University Hospital (NMH) where I was director of IBD and later division chief of GI. My clinical interest is caring for severe refractory IBD. I have been funded through NIH and VA mechanisms x 30yr & currently study epithelial responses in colitis. The primary interest of our laboratory is the impact of mitochondrial respiration in regulating epithelial cell responses in colitis (RO1-funded). This project led to the development of a novel drug (PCT patent pending), AuPhos, that increases mitochondrial function in the intestine and treats colitis in mice (VA merit-funded).

Personal Statement

I focus on patient-oriented care with an in-depth understanding of current and future consequences of disease activity.

Faculty Rank

  • Professor, Department of Medicine, Division of Digestive Disease and Nutrition

Training & Education

Degree

MD, University of Illinois Chicago, Chicago, Ill.
BS, University of Notre Dame, Notre Dame, Ind.

Residency

Internal Medicine, Rush Presbyterian St. Luke's Hospital, Chicago, Ill.

Fellowship

Gastroenterology, University of Chicago IBD, Chicago, Ill.
Immunology, University of Chicago, Chicago, Ill.

Certifications and Special Training

American Board of Internal Medicine
American Board of Gastroenterology

Research

Programs

Translational Oncology

College & Department

Contact Information

MN649
W.M. R. Willard Medical Education Building
Lexington, KY 40536
United States

Phone
(312) 479-4122
Email
t.barrett@uky.edu

Publications

  1. "Epithelial TNF Receptor Signaling Promotes Mucosal Repair in Inflammatory Bowel Disease."
    Bradford, E.M.;Ryu, S.H.;Singh, A.P.;Lee, G.;Goretsky, T.;Sinh, P.;Williams, D.B.;Cloud, A.L.;Gounaris, E.;Patel, V.;Lamping, O.F.;Lynch, E.B.;Moyer, M.P.;De Plaen, I.G.;Shealy, D.J.;Yang, G.Y.;Barrett, T.A. Journal of immunology (Baltimore, Md. : 1950) 199, 5 (2017): 1886-1897.
  2. "Interdependency of EGF and GLP-2 Signaling in Attenuating Mucosal Atrophy in a Mouse Model of Parenteral Nutrition."
    Feng, Y.;Demehri, F.R.;Xiao, W.;Tsai, Y.H.;Jones, J.C.;Brindley, C.D.;Threadgill, D.W.;Holst, J.J.;Hartmann, B.;Barrett, T.A.;Teitelbaum, D.H.;Dempsey, P.J. Cellular and molecular gastroenterology and hepatology 3, 3 (2017): 447-468.
  3. "Predictors of Chronic Opioid Use in Newly Diagnosed Crohn's Disease."
    Pauly, N.J.;Michailidis, L.;Kindred, M.G.;Flomenhoft, D.;Lofwall, M.R.;Walsh, S.L.;Talbert, J.C.;Barrett, T.A. Inflammatory bowel diseases 23, 6 (2017): 1004-1010.
  4. "Myo-inositol reduces β-catenin activation in colitis."
    Bradford, E.M.;Thompson, C.A.;Goretsky, T.;Yang, G.Y.;Rodriguez, L.M.;Li, L.;Barrett, T.A. World journal of gastroenterology 23, 28 (2017): 5115-5126.
  5. "Epithelial PIK3R1 (p85) and TP53 Regulate Survivin Expression during Adaptation to Ileocecal Resection."
    Cohran, V.;Managlia, E.;Bradford, E.M.;Goretsky, T.;Li, T.;Katzman, R.B.;Cheresh, P.;Brown, J.B.;Hawkins, J.;Liu, S.X.;De Plaen, I.G.;Weitkamp, J.H.;Helmrath, M.;Zhang, Z.;Barrett, T.A. The American journal of pathology 186, 7 (2016): 1837-46.